Search
Vectra DA
Contraindications:
- monitoring disease activity in rheumatoid arthritis*
* at baseline, Vectra DA results mirrored validated clinical measures of disease activity. However, at 3 months, 1 year, & 2 years, no association was found between Vectra DA scores & disease activity or radiographic progression [1]
Principle:
- unknown
- measures 12 different biomarkers
Notes:
- test costs about US $1000 [1]
General
laboratory panel
References
- Fleischmann R, Connolly SE, Maldonado MA, Schiff M
Brief report: Estimating disease activity using multi-biomarker
disease activity scores in rheumatoid arthritis patients
treated with abatacept or adalimumab.
Arthritis Rheumatol 2016 Sep; 68:2083
PMID: 27111089
http://onlinelibrary.wiley.com/doi/10.1002/art.39714/abstract